Eric H Kraut Selected Research

pyrazine-2-diazohydroxide (diazohydroxide)

2/2002

A phase II trial of pyrazine diazohydroxide in patients with disseminated malignant melanoma and no prior chemotherapy--Southwest Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eric H Kraut Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 01/2002
6	Neutropenia 09/2020 - 03/2003
5	Thrombocytopenia (Thrombopenia) 01/2022 - 03/2003
5	Anemia 01/2022 - 07/2008
4	Multiple Myeloma 02/2014 - 10/2005
3	acquired Thrombotic thrombocytopenic purpura 12/2009 - 11/2007
2	Nausea 01/2013 - 01/2003
2	Vomiting 01/2013 - 01/2003
2	Hairy Cell Leukemia 03/2012 - 03/2003
2	Agranulocytosis (Granulocytopenia) 12/2011 - 04/2011
2	Exanthema (Rash) 12/2011 - 03/2011
2	Lymphoma (Lymphomas) 01/2010 - 01/2002
2	Thrombotic Thrombocytopenic Purpura 11/2007 - 01/2007
2	Colorectal Neoplasms (Colorectal Cancer) 07/2006 - 10/2002
1	Myoclonic dystonia 01/2022
1	Menorrhagia 01/2022
1	Febrile Neutropenia 01/2022
1	Hemorrhage 01/2022
1	COVID-19 09/2020
1	Cytopenia 02/2014
1	Diarrhea 02/2014
1	Retinoblastoma (Glioblastoma, Retinal) 02/2014
1	Lymphopenia (Lymphocytopenia) 05/2013
1	Triple Negative Breast Neoplasms 05/2013
1	Opportunistic Infections (Opportunistic Infection) 05/2013
1	Fatigue 09/2011
1	Plasma Cell Neoplasms 09/2011
1	Breast Neoplasms (Breast Cancer) 04/2011
1	Squamous Cell Carcinoma of Head and Neck 03/2011
1	Infections 03/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2010
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2010
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2010
1	Lung Neoplasms (Lung Cancer) 12/2009
1	Chronic Renal Insufficiency 01/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 06/2008
1	Disease Progression 11/2007
1	Iron Overload 10/2006
1	Splenomegaly 03/2003
1	Leukemia 01/2003
1	Fever (Fevers) 01/2003
1	Melanoma (Melanoma, Malignant) 02/2002

Drug/Important Bio-Agent (IBA)

4	thiamine triphosphorate (TTP)IBA 12/2009 - 01/2007
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2020
3	alvocidib (flavopiridol)IBA 02/2014 - 01/2010
3	Rituximab (Mabthera)FDA Link 03/2012 - 03/2003
3	Topotecan (Hycamtin)FDA LinkGeneric 12/2011 - 01/2002
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2008 - 01/2007
2	DNA (Deoxyribonucleic Acid)IBA 05/2013 - 02/2002
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2013 - 03/2011
2	IronIBA 05/2012 - 10/2006
2	HematinicsIBA 05/2012 - 01/2009
2	Pentostatin (Nipent)FDA LinkGeneric 03/2012 - 03/2003
2	ElectrolytesIBA 09/2011 - 01/2003
2	fludarabineIBA 01/2010 - 01/2003
2	Biomarkers (Surrogate Marker)IBA 12/2009 - 12/2008
2	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2007 - 01/2007
1	Sarcoglycans (beta Sarcoglycan)IBA 01/2022
1	serum P-component (CIt)IBA 01/2022
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 09/2020
1	Thrombopoietin (c-mpl Ligand)IBA 09/2020
1	Cyclin D1IBA 02/2014
1	Transaminases (Aminotransferases)IBA 02/2014
1	Bendamustine Hydrochloride FDA Link 05/2013
1	ErbB Receptors (EGF Receptor)IBA 05/2013
1	Cisplatin (Platino)FDA LinkGeneric 01/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2013
1	Semaxinib (SU5416)IBA 01/2013
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2013
1	Gemcitabine FDA Link 12/2011
1	SteroidsIBA 12/2011
1	temsirolimus FDA Link 09/2011
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2011
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 09/2011
1	Lenalidomide (CC 5013)FDA Link 09/2011
1	NSC 366140 (pyrazoloacridine)IBA 04/2011
1	Nucleic AcidsIBA 04/2011
1	Docetaxel (Taxotere)FDA Link 03/2011
1	Proteins (Proteins, Gene)FDA Link 01/2010
1	Diphosphonates (Bisphosphonates)IBA 12/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2008
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 06/2008
1	5-chloroquinoxaline-2-sulfanilamide (chloroquinoxaline sulfonamide)IBA 07/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2005
1	Purine NucleosidesIBA 03/2003
1	CytokinesIBA 03/2003
1	Adenosine DeaminaseIBA 03/2003
1	Antisense OligonucleotidesIBA 01/2003
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2003
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2003
1	oblimersen (G3139)IBA 01/2003
1	PyrazinesIBA 02/2002

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
5	Therapeutics 05/2013 - 11/2007
3	Plasma Exchange 12/2009 - 01/2007
1	Cannula 01/2022
1	Treatment Delay 01/2013
1	Drug Tapering 04/2011